[Our clinical experience in the treatment of diabetes mellitus with Glybenclamide].
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005247:Feeding Behavior; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008111:Liver Function Tests; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D014044:Tolbutamide; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin